Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Homocysteine-lowering therapy: a role in stroke prevention?

Spence, J David · 2007 · The Lancet Neurology

Abstract

On the basis of the results of several recent clinical trials, many researchers have concluded that vitamin therapy designed to lower total homocysteine concentrations is not effective in reducing the risk of cardiovascular events. However, whereas almost all myocardial infarctions are due to plaque rupture, stroke has many more pathophysiological mechanisms, and thrombosis-which is increased by raised total homocysteine concentrations-has an important role in many of these processes. Thus, stroke and myocardial infarction could respond differently to vitamin therapy. A detailed assessment of the results of the recent HOPE-2 trial and a reanalysis of the VISP trial restricted to patients capable of responding to vitamin therapy suggest that higher doses of vitamin B12 and perhaps new approaches to lowering total homocysteine besides routine vitamin therapy with folate, vitamin B6, and vitamin B12 could reduce the risk of stroke. Thus, therapy to lower homocysteine could still help to prevent stroke, if not other vascular outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(07)70219-3

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 113 references

Research works printed but not linked: 5

  1. Klinke, 1998, [Effect of vitamin therapy on homocyst(e)ine, fibrinogen and Lp(a) in dialysis patients], Czynniki Ryzyka Suppl, 4, 28
  2. Wilson, 2007, Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice, Arterioscler Thromb Vasc Biol, 27, 233, 10.1161/01.atv.0000251607.96118.af · DOI
  3. Werstuck, 2001, Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways, J Clin Invest, 107, 1263, 10.1172/jci11596 · DOI · Paper page
  4. Hossain, 2003, TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia, J Biol Chem, 278, 30317, 10.1074/jbc.m212897200 · DOI · Paper page
  5. Zhou, 2004, Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice, Circulation, 110, 207, 10.1161/01.cir.0000134487.51510.97 · DOI · Paper page

Cited by

See all 234

Metadata

Authors
Spence, J. D.
Affiliations
Robarts Research Institute (CA)
Corresponding author
Spence, J David
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2007-09
Volume
6
Issue
9
Pages
830-838
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2150352511
Cited by
220
References
113
Citations by year
2026: 1 · 2025: 9 · 2024: 11 · 2023: 9 · 2022: 8 · 2021: 13 · 2020: 7 · 2019: 16 · 2018: 18 · 2017: 12 · 2016: 7 · 2015: 12 · 2014: 7 · 2013: 13 · 2012: 15
FWCI
2.31
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
homocysteine-lowering therapy, stroke prevention, hyperhomocysteinemia, vitamin B12, folic acid, vitamin B6, thrombosis, myocardial infarction, cardiovascular risk
MeSH terms
Animals, Clinical Trials as Topic, Homocysteine, Humans, Myocardial Infarction, Risk, Vitamin B 12, Stroke, Vitamin B 6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Homocysteine-lowering therapy: a role in stroke prevention? https://app.cochat.ai/papers/10.1016/s1474-4422(07)70219-3
The paper
Spence, J. D. (2007). Homocysteine-lowering therapy: a role in stroke prevention? The Lancet Neurology. https://doi.org/10.1016/s1474-4422(07)70219-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.